NEJM at AHA - CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy

N Engl J Med. 2024 Dec 12;391(23):e62. doi: 10.1056/NEJMe2414473. Epub 2024 Nov 16.

No abstract available

Publication types